1. Kashofer K, Gornicec M, Lind K, Caraffini V, Schauer S, Beham-Schmid C, et al. Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing. Leuk Lymphoma. 2018 Feb 1;59(2):501–4.
2. Wang HQ, Li J. Clinicopathological features of myeloid sarcoma: report of 39 cases and literature review. Pathol Res Pract. 2016 Sep 1;212(9):817–24.
3. Vardiman JW. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms. Chem Biol Interact. 2010 Mar 19;184(1–2):16–20.
4. Ohanian M, Faderl S, Ravandi F, Pemmaraju N, Garcia-Manero G, Cortes J, et al. Is acute myeloid leukemia a liquid tumor? Int J Cancer. 2013 Aug 1;133(3):534–43.
5. Tsimberidou AM, Kantarjian HM, Wen S, Keating MJ, O’Brien S, Brandt M, et al. Myeloid sarcoma is associated with superior event‐free survival and overall survival compared with acute myeloid leukemia. Cancer. 2008 Sep 15;113(6):1370–8.